Exhibit 99.1
INFORMATION REGARDING THE MANAGERS OF SVLSF IV, LLC and ILSF III, LLC
The names and the principal occupation of the current managers of SVLSF IV, LLC and ILSF III, LLC, respectively, are set forth below. The business address of David Milne, James Garvey, Eugene D. Hill, III, Michael Ross and Denise Marks is One Boston Place, 201 Washington Street, Suite 3900, Boston, MA 02108. The business address of Kate Bingham and Nick Coleman is 71 Kingsway, London, United Kingdom WC2B 6ST.
During the last five years, none of the individuals has been convicted in any criminal proceeding (excluding traffic violations and similar misdemeanors) or has been a party to any civil proceeding of a judicial or administrative body as a result of which such person was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding violations with respect to such laws.
SVLSF IV, LLC
Position with LLC | Principal occupation | Shares of Entellus Medical, Inc. beneficially owned | Description of | Citizenship | ||||||||
David Milne | Manager | Managing Partner; International life sciences venture capital investments; (also member of the board of directors of Entellus Medical, Inc.) | 1,250 | (1) | Not applicable | USA | ||||||
James Garvey | Manager | Chairman Emeritus; International life sciences venture capital investments | -0- | Not applicable | USA | |||||||
Kate Bingham | Manager | Managing Partner; International life sciences venture capital investments | -0- | Not applicable | United Kingdom | |||||||
Eugene D. Hill, III | Manager | Chairman; International life sciences venture capital investments | -0- | Not applicable | USA | |||||||
Michael Ross | Manager | Managing Partner; International life sciences venture capital investments | -0- | Not applicable | USA | |||||||
Denise W. Marks | Administrative Member | Administrative Member | -0- | Not applicable | USA | |||||||
Nick Coleman | Administrative Member | Administrative Member | -0- | Not applicable | United Kingdom | |||||||
| (1) | Includes shares underlying an option which has vested or will vest within 60 days of the date hereof. |
ILSF III, LLC
Position with ILSF III, LLC | Principal occupation | Shares of Entellus Medical, Inc. beneficially owned | Description of any contract, | Citizenship | ||||||||
| James Garvey | Manager | Chairman Emeritus; International life sciences venture capital investments | -0- | Not applicable | USA | |||||||
| Kate Bingham | Manager | Managing Partner; International life sciences venture capital investments | -0- | Not applicable | United Kingdom | |||||||
| Eugene D. Hill, III | Manager | Chairman; International life sciences venture capital investments | -0- | Not applicable | USA | |||||||
| Michael Ross | Manager | Managing Partner; International life sciences venture capital investments | -0- | Not applicable | USA | |||||||
| Denise W. Marks | Administrative Member | Administrative Member | -0- | Not applicable | USA | |||||||
| Nick Coleman | Administrative Member | Administrative Member | -0- | Not applicable | United Kingdom | |||||||
